MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hallucinations"

  • 2019 International Congress

    A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment

    K. Amodeo (Rochester, NY, USA)

    Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…
  • 2019 International Congress

    Cognitive dysfunction in patients with Parkinson’s disease and psychosis

    A. Lenka, S. Hegde, S. Arumugham, R. Yadav, P. Pal (Washington, DC, USA)

    Objective: The objective of this study was to explore the pattern of cognitive dysfunction in the patient's with Parkinson's disease and psychosis (PD-P) by comparing…
  • 2019 International Congress

    The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations

    A. Powell, J. Shine, S. Lewis (Sydney, Australia)

    Objective: To examine changes in functional connectivity in patients with Parkinson’s disease (PD) and visual hallucinations (VH) on and off dopaminergic medication. Background: Symptoms on…
  • 2019 International Congress

    Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

    B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

    Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…
  • 2019 International Congress

    Impaired colour discrimination is associated with hallucinations in Dementia with Lewy Bodies

    E. Matar, K. Ehgoetz Martens, J. Phillips, G. Halliday, S. Lewis (Sydney, Australia)

    Objective: To explore the hypothesis that color discrimination impairment seen in Lewy body disorders is a specific biomarker of visual hallucinations rather than just overall…
  • 2019 International Congress

    Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

    A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)

    Objective: To test whether increased reliance on prior knowledge is associated with visual hallucinations in Lewy Body Disease (LBD: Parkinson’s disease and Dementia with Lewy…
  • 2019 International Congress

    Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease

    O. Alenikova, S. Likhchev, A. Buniak, M. Liashkovich (Minsk, Belarus)

    Objective: To assess the daily variability of visual and autonomic nervous system (ANS) functions in relation to sleep disorders to determine circadian PD phenotypes Background:…
  • 2019 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…
  • 2018 International Congress

    Identifying delirium and it prevalence in idiopathic Parkinson’s disease

    R. Lawson, C. McDonald, D. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To determine diagnostic criteria used to identify delirium in Parkinson’s disease (PD) and its prevalence via a systematic literature review. Background: People with PD…
  • 2018 International Congress

    Propranolol Induced Visual Hallucinations: A Case Report Charles Bonnets Syndrome in Parkinson Disease

    M. Şenol, M. Kendirli (Istanbul, Turkey)

    Objective: Charles Bonnets has defined the visual hallucinations (VH) associated with macular degeneration; the syndrome (CBS) is to be remembered by his name. M Background:…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley